Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,117 across all filing types
Latest filing 2025-06-16 Major Shareholding Noti…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Change in substantial holding from MUFG 9 pages 778.8KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001, Section 671B, which pertains to notices of change of interests of substantial holders. The content details changes in voting power, relevant interests, and transactions involving shares by Mitsubishi UFJ Financial Group, Inc. It includes specifics about share purchases and sales, dates of changes, and associations. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of 'Major Shareholding Notification' (Code: MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes. The length and detail confirm it is the actual notice, not just an announcement of a report.
2025-06-16 English
Update on litigation with Cosette 2 pages 145.7KB
Legal Proceedings Report Classification · 100% confidence The document is an ASX announcement dated 16 June 2025 regarding ongoing litigation between Mayne Pharma and Cosette Pharmaceuticals. It details court proceedings, claims, and responses related to the termination of a scheme implementation deed. The content focuses on legal updates and litigation status rather than financial results, management changes, or shareholder voting outcomes. It does not contain financial statements or detailed financial data, nor is it a brief voting result announcement. The document is clearly an update on legal proceedings involving the company, fitting the category of Legal Proceedings Report (LTR). The document length (5474 characters) and detailed narrative support this classification rather than a short announcement or a report publication notice.
2025-06-15 English
MYX receives further purported notice to terminate SID 2 pages 125.3KB
M&A Activity Classification · 95% confidence The document is an ASX announcement dated 13 June 2025 regarding a purported termination notice related to a Scheme Implementation Deed between Mayne Pharma and Cosette Pharmaceuticals. It discusses legal and procedural updates about the scheme and shareholder meeting arrangements. There is no detailed financial data, no full report, no earnings release, no audit information, and no management discussion. The content is focused on corporate actions related to a merger or acquisition scheme and related notices. This fits the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2025-06-12 English
Becoming a substantial holder from MS 46 pages 3.1MB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603' and references the Corporations Act 2001, Section 671B, which pertains to notices of initial substantial holders. The content details the substantial shareholding of Morgan Stanley and its subsidiaries in Mayne Pharma Group Limited, including voting power, relevant interests, registered holders, and consideration paid for shares. This type of filing is a notification of a major shareholding or change in significant ownership levels, consistent with the definition of Major Shareholding Notification (MRQ). The document is lengthy (15,000 characters) and contains detailed shareholding data, not just an announcement or summary, confirming it is the actual notification filing.
2025-06-10 English
Change in substantial holding from MUFG 6 pages 762.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, specifically a "Notice of change of interests of substantial holder" for Mayne Pharma Group Limited. It details changes in voting power and relevant interests of Mitsubishi UFJ Financial Group, Inc., including annexures listing specific share purchases. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification (MRQ). The document is substantive and not merely an announcement or certification, and it does not fit other categories such as financial reports or management information.
2025-06-10 English
Change in substantial holding 1 page 109.0KB
Major Shareholding Notification Classification · 95% confidence The document is a letter addressed to the Market Announcements Office of ASX Limited, correcting a previously filed Form 604 related to a notifiable change in interest in Mayne Pharma Group Ltd (MYX). Form 604 is a regulatory filing used to notify changes in substantial shareholdings. The document does not contain financial statements, management discussion, or detailed report content. It is a correction notice regarding a shareholding notification. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and it is a direct notification, not an announcement of a report or a certification. Hence, the classification is MRQ with high confidence.
2025-06-10 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.